, /PRNewswire/ — Quantum Computing Inc. (“QCi” or the “Company”) (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today announced a collaboration with Sanders Tri-Institutional Therapeutics Discovery Institute, Inc. (Sanders TDI) to drive advancement of research in computational biomedicine. Through this collaboration, QCi will provide Sanders TDI with access to its quantum computation technology and hardware, specifically with its Dirac-3 Entropy Quantum Computing Machine, to support the Institute’s experimental work.
Sanders TDI is a non-profit drug discovery institute based in New York City, composed of Kettering Cancer Center, The Rockefeller University, and Memorial Sloan Weill Cornell Medicine. The Institute’s mission is to advance their groundbreaking biological discoveries to preclinical studies, focusing on the relevance of these findings for blocking disease initiation and progression. In addition, Sanders TDI provides industrial-scale technical support for academic research and projects.
As part of the collaboration, QCi will offer Sanders TDI cloud-based access to its Dirac-3 systems, which …